FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3523401000001104: Ursofalk 250mg/5mL suspension


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    7271701000001114 Ursofalk 250mg/5mL suspension en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    7828801000001116 Ursofalk 250mg/5mL suspension en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Ursofalk 250mg/5mL suspension Is a Ursodeoxycholic acid 250mg/5mL s/f suspension - product false Inferred relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension Availability Product is currently available false Additional relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension Legal category Prescription Only Medicine false Additional relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension CSM recommendation to report adverse reactions Report only serious adverse reactions to the Committee on Safety of Medicines false Additional relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension Product name type Brand name false Additional relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension Has active ingredient Ursodeoxycholic acid false Inferred relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension Has active ingredient Bile false Inferred relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension Has active ingredient Gallstone solubilizing agent false Inferred relationship Existential restriction modifier
    Ursofalk 250mg/5mL suspension Has active ingredient Ursodiol false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start